Loading clinical trials...

Effectiveness and Safety of Probiotics in Relieving Anxiety and Depression | Clinical Trials | Clareo Health

COMPLETEDNA

Effectiveness and Safety of Probiotics in Relieving Anxiety and Depression

Effectiveness and Safety of Probiotics, BC99 in Relieving Anxiety and Depression in Adults

NCT06629441•Wecare Probiotics Co., Ltd.

Summary

To evaluate the effectiveness and safety of probiotics in relieving anxiety and depression in adults, in comparison with placebo.

Eligibility

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Voluntary, Written, and Signed Informed Consent: Agreeing to participate in the study.
•2. Ability to Complete the Study According to Protocol: Able to meet the requirements of the study protocol.
•3. Age: 18-65 years old.
•4. Depression and Anxiety Scores:
•* Hamilton Depression Rating Scale (HAMD-17) score of 20 or higher, or
•* Hamilton Anxiety Rating Scale (HAMA) score of 14 or higher.
•5. No History of Certain Conditions: No history of heart, liver, kidney, nervous system, psychiatric disorders, or metabolic abnormalities.

Exclusion Criteria

•1. Past Diagnosis of Certain Conditions: Individuals with a history of other clearly diagnosed psychiatric disorders, intellectual disabilities, consciousness disorders, complete aphasia, bipolar disorder, treatment-resistant depression, or suicidal thoughts.
•2. Pregnant or Breastfeeding Women: Individuals who are pregnant or breastfeeding.
•3. Use of Certain Medications: Individuals who have used anti-anxiety, anti-depressant medications, or mood stabilizers within the past month.
•4. Allergy History: Individuals with allergic constitutions or a history of drug allergies, or those with severe systemic diseases.
•5. Substance Abuse History: Individuals with a history of alcohol or psychoactive substance abuse within the past 3 months.
•6. Impact of Medications on Gut Microbiota: Individuals who have used medications affecting gut microbiota (including antibiotics, probiotics, mucosal protectors, traditional Chinese medicine, etc.) continuously for more than 1 week in the month prior to screening.
•7. Discontinuation or Addition of Medications: Individuals who have stopped taking the study medication or started taking other medications, making it difficult to assess efficacy or with incomplete data.
•8. Use of Similar Products: Individuals who have taken items similar to the study product in the short term, affecting the evaluation of results.
•9. Inability to Participate: Research participants who cannot participate in the study due to personal reasons.
•10. Other Exclusions: Participants deemed unsuitable for the study by the researchers.

Locations (1)

The 1st Affiliated Hospital of He'nan University of Science and Technology

Luoyang, Henan, China

Key Dates

Start Date

June 20, 2024

Primary Completion Date

December 15, 2024

Completion Date

January 14, 2025

Last Updated

August 19, 2025

Enrollment

ACTUAL participants

Conditions

Anxiety Depression

Interventions

Probiotic group

DIETARY_SUPPLEMENT

Placebo group

DIETARY_SUPPLEMENT

Group Therapy Using the "I-Reconstruction" Psychotherapy Method to Reduce Anxiety Levels

NCT07397429

AnxietyAnxiety Depression

View study

RECRUITING

CBT and the Neural Circuits of Anxiety

NCT05549102

Generalised Anxiety DisorderAnxiety Disorders+7 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 19, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Effectiveness and Safety of Probiotics in Relieving Anxiety and Depression

Inclusion Criteria

Exclusion Criteria

Group Therapy Using the "I-Reconstruction" Psychotherapy Method to Reduce Anxiety Levels

CBT and the Neural Circuits of Anxiety

Probiotics Regulate Intestinal Health and Alleviate Anxiety

Acupuncture for Anxiety/Depression in Patients With Breast Cancer

Exploratory Study for Toivoa-001 on Human Factors

SFGT for Persistent Anxiety and Depression